Your browser doesn't support javascript.
From predictions to prescriptions: A data-driven response to COVID-19.
Bertsimas, Dimitris; Boussioux, Leonard; Cory-Wright, Ryan; Delarue, Arthur; Digalakis, Vassilis; Jacquillat, Alexandre; Kitane, Driss Lahlou; Lukin, Galit; Li, Michael; Mingardi, Luca; Nohadani, Omid; Orfanoudaki, Agni; Papalexopoulos, Theodore; Paskov, Ivan; Pauphilet, Jean; Lami, Omar Skali; Stellato, Bartolomeo; Bouardi, Hamza Tazi; Carballo, Kimberly Villalobos; Wiberg, Holly; Zeng, Cynthia.
  • Bertsimas D; Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. dbertsim@mit.edu.
  • Boussioux L; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. dbertsim@mit.edu.
  • Cory-Wright R; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Delarue A; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Digalakis V; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Jacquillat A; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Kitane DL; Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
  • Lukin G; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Li M; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Mingardi L; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Nohadani O; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Orfanoudaki A; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Papalexopoulos T; Benefits Science Technologies, Boston, MA 02110, USA.
  • Paskov I; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Pauphilet J; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Lami OS; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Stellato B; London Business School, London, NW1 4SA, UK.
  • Bouardi HT; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Carballo KV; Operations Research and Financial EngineeringPrinceton University, Princeton, NJ, 08544, USA.
  • Wiberg H; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Zeng C; Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Health Care Manag Sci ; 24(2): 253-272, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1085646
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a comprehensive data-driven approach to understand the clinical characteristics of COVID-19, predict its mortality, forecast its evolution, and ultimately alleviate its impact. By leveraging cohort-level clinical data, patient-level hospital data, and census-level epidemiological data, we develop an integrated four-step approach, combining descriptive, predictive and prescriptive analytics. First, we aggregate hundreds of clinical studies into the most comprehensive database on COVID-19 to paint a new macroscopic picture of the disease. Second, we build personalized calculators to predict the risk of infection and mortality as a function of demographics, symptoms, comorbidities, and lab values. Third, we develop a novel epidemiological model to project the pandemic's spread and inform social distancing policies. Fourth, we propose an optimization model to re-allocate ventilators and alleviate shortages. Our results have been used at the clinical level by several hospitals to triage patients, guide care management, plan ICU capacity, and re-distribute ventilators. At the policy level, they are currently supporting safe back-to-work policies at a major institution and vaccine trial location planning at Janssen Pharmaceuticals, and have been integrated into the US Center for Disease Control's pandemic forecast.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Machine Learning / COVID-19 / COVID-19 Drug Treatment Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Health Care Manag Sci Journal subject: Health Services Year: 2021 Document Type: Article Affiliation country: S10729-020-09542-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Machine Learning / COVID-19 / COVID-19 Drug Treatment Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Health Care Manag Sci Journal subject: Health Services Year: 2021 Document Type: Article Affiliation country: S10729-020-09542-0